date:Sep 15, 2012
China is setting the regional benchmark for innovation in premium infant foods, according to Enzymotec, the Israel-based lipids-maker.
The company was speaking after the announcement this week that clinical trials for its lipid-based ingredient line for infant nutrition had yielded positive results.
The trials were part of its strategy to market a line of products mimicking the vital lipids found in mothers milk, such as triglyceride, phospholipids and long-chain polyunsaturated fatty acids.